These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35940529)

  • 1. N-Acetylcysteine as Prophylactic Therapy for Transplantation-Associated Thrombotic Microangiopathy: A Randomized, Placebo-Controlled Trial.
    Pan T; Qi J; Tang Y; Yao Y; Chen J; Wang H; Yang J; Xu X; Shi Q; Liu Y; He X; Chen F; Ma X; Hu X; Wu X; Wu D; Han Y
    Transplant Cell Ther; 2022 Nov; 28(11):764.e1-764.e7. PubMed ID: 35940529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
    Benítez Carabante MI; Bueno D; Alonso García L; López Torija I; Marsal J; Fernandez Navarro JM; Uria Oficialdegui ML; Panesso M; Molina B; Beléndez Bieler C; Palomo P; Pérez Martínez A; Diaz-de-Heredia C
    Transplant Cell Ther; 2024 Jun; 30(6):601.e1-601.e13. PubMed ID: 38521410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
    Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation.
    Koo J; Ziady AG; Reynaud D; Abdullah S; Luebbering N; Kahn S; Langenberg L; Strecker L; Lake K; Dandoy CE; Lane A; Myers KC; Sabulski A; Good S; Nalapareddy K; Solomon M; Siefert ME; Skala E; Jodele S; Davies SM
    Transplant Cell Ther; 2023 Nov; 29(11):704.e1-704.e8. PubMed ID: 37625594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis.
    Higham CS; Collins G; Shimano KA; Melton A; Kharbanda S; Winestone LE; Huang JN; Dara J; Long-Boyle JR; Dvorak CC
    Blood Adv; 2021 Apr; 5(8):2106-2114. PubMed ID: 33877298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy.
    Pan T; Qi J; You T; Han S; Yang L; Miao W; Wu D; Ruan C; Zhu L; Han Y
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1486-1491. PubMed ID: 30871975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.
    Postalcioglu M; Kim HT; Obut F; Yilmam OA; Yang J; Byun BC; Kupiec-Weglinski S; Soiffer R; Ritz J; Antin JH; Alyea E; Koreth J; Cutler C; Armand P; Paik JM; Leaf DE; Ho VT; Abdi R
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2344-2353. PubMed ID: 29758394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
    Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
    Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
    Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
    Front Immunol; 2021; 12():695037. PubMed ID: 34326846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients.
    Higham CS; Shimano KA; Melton A; Kharbanda S; Chu J; Dara J; Winestone LE; Hermiston ML; Huang JN; Dvorak CC
    Pediatr Blood Cancer; 2022 May; 69(5):e29641. PubMed ID: 35253361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant.
    Dandoy CE; Rotz S; Alonso PB; Klunk A; Desmond C; Huber J; Ingraham H; Higham C; Dvorak CC; Duncan C; Schoettler M; Lehmann L; Cancio M; Killinger J; Davila B; Phelan R; Mahadeo KM; Khazal S; Lalefar N; Vissa M; Myers K; Wallace G; Nelson A; Khandelwal P; Bhatla D; Gloude N; Anderson E; Huo J; Roehrs P; Auletta JJ; Chima R; Lane A; Davies SM; Jodele S
    Blood Adv; 2021 Jan; 5(1):1-11. PubMed ID: 33570619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study.
    Svec P; Elfeky R; Galimard JE; Higham CS; Dalissier A; Quigg TC; Bueno Sanchez D; Han Lum S; Faraci M; Cole T; Pichler H; Benítez-Carabante MI; Horakova J; Gonzalez-Vicent M; Yanir A; Fagioli F; Wölfl M; von der Weid N; Protheroe R; Krivan G; Speckmann C; James B; Avcin SL; Bertrand Y; Verna M; Riha P; Patrick K; Cesaro S; Kalwak K; Bierings M; Büchner J; Mellgren K; Prohászka Z; Neven B; Lankester A; Corbacioglu S
    Bone Marrow Transplant; 2023 Feb; 58(2):129-141. PubMed ID: 36333550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
    Jodele S; Dandoy CE; Sabulski A; Koo J; Lane A; Myers KC; Wallace G; Chima RS; Teusink-Cross A; Hirsch R; Ryan TD; Benoit S; Davies SM
    Transplant Cell Ther; 2022 Jul; 28(7):392.e1-392.e9. PubMed ID: 35490975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acetyl-L-Cysteine Potentially Inhibits Complement Activation in Transplantation-Associated Thrombotic Microangiopathy.
    Qi J; Hu S; He X; Pan T; Yang L; Zhang R; Tang Y; Wu D; Han Y
    Transplant Cell Ther; 2022 Apr; 28(4):216.e1-216.e5. PubMed ID: 34979328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis.
    Zhang R; Zhou M; Qi J; Miao W; Zhang Z; Wu D; Han Y
    Front Immunol; 2020; 11():564647. PubMed ID: 33552043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy.
    Higham CS; Shimano KA; Kharbanda S; Chu J; Cisneros GS; Winestone LE; Dara J; Huang JN; Hermiston ML; Long-Boyle JR; Dvorak CC
    Transplant Cell Ther; 2024 Sep; 30(9):931.e1-931.e10. PubMed ID: 38944154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
    Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
    Sartain S; Shubert S; Wu MF; Wang T; Martinez C
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.